Improving cancer control and vaccination efforts in Nigeria
Official title: Administrative and Engagement Core
Funded at Washington University · NIH-10931741 · Data updated 2026-11-12
This study is all about working together with doctors, communities, and the government in Nigeria to improve cancer prevention, especially by promoting cervical cancer vaccinations, so that everyone can get better care and support for fighting cancer.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Washington University NIH-funded |
| Lab location | 1 site (Saint Louis, United States) |
| Project start | September 19, 2023 |
| Project end | August 31, 2028 |
| Funding year | 2024 |
| Award (this year) | $175,097 |
| NIH project number | 5U54CA284110-02 |
| Project ID | NIH-10931741 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit from this research include individuals at risk for cervical cancer, particularly women in Nigeria.
✕Less likely to help
Patients with cancers unrelated to cervical cancer or those outside the Nigerian healthcare system may not receive benefits from this research.
What this research studies
This research aims to enhance cancer control in Nigeria by fostering partnerships between healthcare providers, communities, and government agencies. It focuses on implementing guidelines and strategies for cancer prevention, particularly through vaccination efforts against cervical cancer. The project will engage local stakeholders to ensure that cancer control measures are effectively integrated into public health initiatives. By leveraging existing frameworks and resources, the research seeks to create sustainable improvements in cancer care and prevention.
Why it matters
Potential benefit: If successful, this research could lead to a significant reduction in cancer incidence and mortality in Nigeria through improved vaccination and cancer control strategies.
How similar studies have gone: Previous research has shown success in implementing cancer control strategies and vaccination programs in similar contexts, indicating potential for positive outcomes in this initiative.
Where this research is happening
-
Washington University
Saint Louis, United States Active
Researchers
- Principal investigator: Iwelunmor, Juliet — Washington University
- Study coordinator: Iwelunmor, Juliet
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.